Related Experiment Videos
Osteosarcoma as a second malignancy after treatment for neuroblastoma
Pediatric Hematology and Oncology
|October 12, 2001
Summary
A rare case of secondary osteosarcoma occurred in a neuroblastoma survivor outside the radiation field. This highlights the importance of long-term monitoring for second cancers in these patients.
Area of Science:
- Pediatric Oncology
- Orthopedic Oncology
- Cancer Survivorship
Background:
- Neuroblastoma is a common pediatric cancer.
- Survivors of childhood cancers face risks of secondary malignancies.
- Radiation therapy is a known risk factor for secondary cancers.
Observation:
- A 4-month-old diagnosed with stage IV neuroblastoma received chemotherapy, surgery, and radiation.
- Nine years post-treatment, the patient developed chondroblastic osteosarcoma in the left ischium, outside the radiation field.
- The patient underwent successful treatment for the secondary osteosarcoma with chemotherapy and limb salvage surgery.
Findings:
- This case presents a rare instance of a second osteosarcoma developing in a neuroblastoma survivor.
- The secondary osteosarcoma occurred outside the prior radiation treatment field.
- The patient achieved disease-free status after treatment for the secondary osteosarcoma.
Implications:
- Close long-term surveillance for second malignant neoplasms is crucial for neuroblastoma survivors.
- The development of secondary cancers may occur even without traditional risk factors like radiation.
- This case underscores the need for vigilance in monitoring neuroblastoma survivors for late-onset malignancies.